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Abstract
Introduction: We present the case of a patient with two tumors in his left kidney and a synchronous colon
cancer. While coexisting tumors have been previously described in the same kidney or the kidney and other
organs, or the colon and other organs, to the best of our knowledge no such concurrency of three primary tumors
has been reported in the literature to date.
Case presentation: A 72-year-old man of Greek nationality presenting with pain in the right hypochondrium
underwent a series of examinations that revealed gallstones, a tumor in the hepatic flexure of the colon and an
additional tumor in the upper pole of the left kidney. He was subjected to a right hemicolectomy, left
nephrectomy and cholecystectomy, and his postoperative course was uneventful. Histopathology examinations
showed a mucinous colon adenocarcinoma, plus two tumors in the left kidney, a papillary renal cell carcinoma and
a chromophobe renal cell carcinoma.
Conclusion: This case underlines the need to routinely scan patients pre-operatively in order to exclude coexisting
tumors, especially asymptomatic renal tumors in patients with colorectal cancer, and additionally to screen
concurrent tumors genetically in order to detect putative common genetic alterations.
Introduction
Synchronous multiple primary tumors are relatively rare.
The etiology and pathogenesis of such multiple tumors
remain unclear. It has been hypothesized that concur-
rent tumors can arise from tissues with similar embryo-
logical origin when they are simultaneously affected by
factors such as carcinogens or hormones. Coexisting
tumors in the colon and kidney are more often diag-
nosed nowadays due to the widespread use of ultrasono-
graphy and computed tomography (CT) or magnetic
resonance imaging (MRI) techniques.
Case presentation
A 72-year-old man of Greek nationality presented to our
facility with pain in the right hypochondrium. He under-
went an abdominal ultrasound, which revealed multiple
gallstones and a 4 × 3.3 cm tumor in the upper pole of
the left kidney. Abdominal CT and MRI scans showed a
4 cm solid tumor at the external margin of the left kid-
ney that extended up to the neighboring surface of the
spleen (red arrows in Figures 1 and 2). The scans also
showed a distension of the ascending colon with conco-
mitant wall thickening and dimness of the pericolic fat
tissue (green arrow in Figure 3), findings indicating pos-
sible neoplasia.
Our patient was then admitted to our clinic for
further examination and treatment. From his medical
history he was a smoker of 50 packs/year, had arterial
hypertension and had reported alternating diarrhea and
constipation during the last five years, with no family
history as far as malignancies were concerned. A physi-
cal examination revealed a palpable mass in the right
subcostal region. Laboratory data on admission revealed
hypochromic anemia, with a hemoglobin level of 11.1 g/
dL and an a-fetoprotein level of 7.61 ng/dL; all other
tumor markers were found to be at normal levels. Colo-
noscopy revealed a mass in the hepatic flexure, while a
dimercaptosuccinic acid scan showed that both kidneys
were functioning normally.
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Our patient underwent surgery and was subjected to a
right hemicolectomy, left nephrectomy and cholecystect-
omy. Reconstruction was performed by an end-to-side
ileo-transversostomy. He had an uneventful postopera-
tive course and was discharged nine days later.
The following two specimens were obtained by
our department of pathology for histopathological
examination:
(1) right hemicolectomy composed of a portion of
terminal ileum, cecum with the appendix and ascending
colon with the corresponding pericolic fat tissue.
Grossly, an exophytic grayish tumor (size 5.5 × 5 × 5
cm) was detected in the cecum near the ascending
colon area. Macroscopically the tumor seemed to extend
through the colonic wall. After processing, 27 lymph
nodes were found in the pericolic fat.
(2) Left nephrectomy composed of left kidney (size
12 × 9 × 4 cm), ureter stump and perinephric tissue.
Grossly, two tumors were recognized: one occupied
the upper pole of the kidney (size 4.5 × 4 cm), was
whitish and friable, and was restricted under the
fibrous capsule; the second (size 2.2 × 1.9 cm) was a
gray-brown, well circumscribed, solitary mass, with
regions of hemorrhage and necrosis, near the lower
pole. The distance between these lesions was approxi-
mately 5.5 cm.
Microscopic features
At the histological level we observed pools of extracellu-
lar mucin (>50% of the neoplastic tissue was composed
of mucin) that contained single cancer cells and a malig-
nant epithelium that formed acinar structures and/or
cellular strips. The carcinoma penetrated through the
muscularis propria of the bowel wall. No lymph node
metastasis was detected. The diagnosis made was muci-
nous colon adenocarcinoma, stage Dukes B (Figure 4).
Histological analysis of the renal tumor in the upper
pole revealed a carcinoma, with papillary tubulopapillary
and cystic growth pattern accompanied by fibrovascular
cores and aggregates of foamy macrophages (Figure 5).
The papillae were mostly lined by neoplastic cells with
high nuclear grade, eosinophilic cytoplasm and pseudos-
tratified nuclei and focally by small cells with scanty
cytoplasm arranged in a single layer. Immunohisto-
chemically, the tumor cells exhibited strong cytokeratin
7 immunoreactivity. The second tumor corresponded to
a carcinoma with a solid growth pattern. Large round
cells with abundant cytoplasm, a clear perinuclear halo
and hyperchromatic nuclei were observed. Binucleated
and multi-nucleated tumor cells were also present. The
tumor cells were epithelial membrane antigen (EMA)
and cytokeratin immunopositive, and vimentin negative,
Figure 1 Computed tomography (CT) scan showing the tumor
at the external margin of the left kidney (red arrow).
Figure 2 MRI scan showing the tumor at the external margin
of the left kidney (red arrow).
Figure 3 Computed tomography (CT) scan showing distension
of the ascending colon with concomitant wall thickening and
dimness of the pericolic fat tissue (green arrow).
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while Hale’s colloidal iron staining showed a reticular
and diffuse staining pattern (Figure 6). Histopathological
analysis led to a diagnosis of papillary renal cell carci-
noma type 2 and focally type 1, grade 2 to 3; Furhman
grading system, (pT1b) for the tumor of the upper pole
(Figure 5) and chromophobe renal cell carcinoma
(pT1a) for the tumor of the lower pole of the kidney
(Figure 6), respectively.
Discussion
In our patient, we observed the coexistence of three
individual primary tumors, one in the colon and two in
the left kidney. These tumors covered the criteria set by
Warren and Gates for the diagnosis of multiple primary
malignant synchronous tumors [1]. To the best of our
knowledge, no case with such a concurrency has been
reported to date in the literature (Table 1 and [2-21]).
An exophytic grayish tumor (size 5.5 × 5 × 5 cm) was
localized in the cecum and diagnosed as a mucinous
colon adenocarcinoma with no lymph node metastasis;
stage Dukes B. These tumors include many high-
frequency microsatellite instability (MSI-H) carcinomas.
It has been suggested that the MSI status influences the
aggressiveness of this histopathological subtype [22].
When these tumors develop in the rectum they exhibit
the poorest overall prognosis [23]. However, other stu-
dies report that no significant difference in prognosis
between mucinous and non-mucinous types of adeno-
carcinoma exists.
In the left kidney two tumors were observed. The first
one, whitish and friable (size 4.5 × 4 cm), occupying the
upper pole of the kidney and the other (size 2.2 × 1.9
cm) presenting as a gray-brown well circumscribed, soli-
tary mass located near the lower pole. Histopathological
examination revealed papillary renal cell carcinoma type
2 and focally type 1, grade 2 to 3 (pT1b) for the first
tumor and chromophobe renal cell carcinoma (pT1a)
for the second.
Papillary renal cell carcinomas (PRCCs) comprise
approximately 10% of renal cell carcinomas and are
known to originate from the distal convoluted tubule.
The most common genetic aberrations detected in these
carcinomas are trisomy or tetrasomy 7, trisomy 17 and
loss of chromosome Y. Other alterations reported are
interstitial loss of heterozygosity (LOH) at 3p, trisomy
12, 16 and 20 related to tumor progression and LOH at
9p13 that is associated with shorter survival. In other
studies comparative genome hybridization (CGH)
Figure 4 Representative area of the mucinous colon
adenocarcinoma, depicting malignant epithelium within pools
of extracellular mucin (hematoxylin and eosin counterstain,
magnification ×100).
Figure 5 Histological section of the papillary renal cell
carcinoma of the upper pole with a papillary, tubulopapillary
and cystic growth pattern of cancer cells (hematoxylin and
eosin counterstain, magnification ×100).
Figure 6 Microscopic view of the chromophobe renal cell
carcinoma of the lower pole. Large round cells with abundant
cytoplasm, a clear perinuclear halo and hyperchromatic nuclei are
evident (hematoxylin and eosin counterstain, magnification ×200).
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analysis revealed more gains of chromosomes 7p and
17p in type 1 carcinomas in comparison to type 2
tumors, while different types of allelic imbalance at 17q
and 9p have also been described. PRCC seems overall to
have a better prognosis than clear cell carcinomas of the
same stage and grade and at lower stages and grades,
but the prognosis is about the same for higher stages
and grades [24]. The five-year survival has been reported
to range from 49% to 84% [25]. Type I seems to have a
significantly better prognosis than clear cell carcinoma
while type II has about the same prognosis as clear cell
carcinoma. Factors such as tumor grade, stage and sar-
comatoid dedifferentiation influence the patient’s
outcome.
Chromophobe renal cell carcinoma is a relatively rare
malignancy that comprises 5% of renal cell carcinomas
[24] and is described to arise from the intercalated cells of
the distal convoluted tubule. These tumors exhibit good
prognosis with a mortality rate of less than 10% [26]. The
main genetic aberrations that characterize these carcino-
mas are losses of chromosomes 1, 2, 6, 10, 13, 17 and 21,
hypodiploid DNA context, as well as telomere shortening.
P53 mutations in 27% of cases and LOH at the 10q23.3
chromosomal region have also been reported.
Many cases of histological distinct renal tumors occur-
ring coincidentally in the same patients have been
reported [27]. Some of them describe coexistence of
renal cell carcinoma with a benign tumor, such as
oncocytoma, angiomyolipoma, leiomyoma and adrenal
adenoma. Others refer to familial cancer syndromes,
which consist of multiple cancers in a single patient or
the presentation of cancer at an earlier age or more
than one family members with the same cancer. For
example, urothelial cancer has been associated with
Lynch syndrome. Two or three concurrent renal cell
tumors have been reported in cases of hybrid tumors
[28] and in Birt-Hogg-Dubé syndrome, but also in
sporadic cases [16]. A recent report by Tyritzis et al.
describes the case of a 57-year-old man with synchro-
nous chromophobe and papillary renal cell carcinoma
within the same kidney. The authors assumed that dif-
ferent renal tumors could arise from cancer stem cells
that follow dissimilar differentiation pathways regulated
by tissue microenvironmental interactions [29]. Another
hypothesis was the evolution of one subtype to another
(as oncocytomas, for example, posses the ability to
evolve into papillary carcinomas [30]), or that one
malignant renal tumor could switch to another type.
The simultaneous occurrence of renal cell carcinoma
with malignancies that develop in other sites has also
been documented. Such malignancies include urological
cancers [10], esophageal carcinomas, colorectal carcino-
mas [2], lung cancer, breast cancer, gynecological can-
cer, sarcoma and non-Hodgkin’s lymphoma. It has been
estimated that urogenital and gastrointestinal tumors
were the most common pairing of synchronous cancers
Table 1 Cases of primary renal tumors coexisting with other primary malignancies
Renal tumor(s) Synchronous tumor(s) Reference
Renal cell carcinoma Colorectal carcinoma Halak et al. [2]
Renal cell carcinoma Gynecological malignancies Cheung Wong et al. [3]
Chromophobe cell carcinoma Papillary renal carcinoma Tyritzis et al. [4]
Renal cell carcinoma Other sites Beisland et al. [5]
Renal cell carcinoma Esophageal carcinoma Kobayashi et al. [6]
Papillary renal carcinoma Heart liposarcoma Gałazka et al. [7]
Renal oncocytoma Endometrioid ovarian and endometrial carcinoma Bezircioğlu et al. [8]
Chromophobe cell carcinoma Urothelial carcinoma Joon Choi et al. [9]
Ipsilateral renal cell carcinoma Urothelial carcinoma of the renal pelvis Leveridge et al. [10]
Renal cell carcinoma Perirenal liposarcoma Kinebuchi et al. [11]
Renal cell carcinoma Central nervous system lymphoma Chang et al. [12]
Renal cell carcinoma Extragonadal retroperitoneal teratoma Ambani et al. [13]
Renal cell carcinoma Non-Hodgkin’s lymphoma (T cell type) Khadilkar et al. [14]
Chromophobe cell carcinoma Carcinoid tumor of the gallbladder Morelli et al. [15]
Renal cell carcinoma Papillary renal carcinoma/chromophobe cell carcinoma Petrolla et al. [16]
Renal cell carcinoma Malignant lymphoma Yagisawa et al. [17]
Transitional cell carcinoma Right colon cancer Kumar et al. [18]
Malignant rhabdoid tumor Brain tumor Adachi et al. [19]
Renal cell carcinoma Uterine cervical adenocarcinoma Yokoyama et al. [20]
Cystic renal cell and squamous cell carcinoma Transitional cell carcinoma of ipsilateral ureter and urinary bladder Charles et al. [21]
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[1]. However, the pathogenetic mechanism responsible
remains unknown.
In a recent study it has been shown that patients with
urological cancer (cancer of the ureter or renal pelvis,
and to a lesser extent patients with bladder or renal par-
enchymal cancer) were found to be at a higher risk for
developing subsequent colon carcinoma than the general
population and vice versa. The authors assumed that
this two-directional association might be driven by com-
mon environmental risk factors (smoking, diet, carcino-
gens), screening bias, a shared genetic predisposition
(mismatch repair defect) or by the effect of treatment of
one type of cancer on the other. As far as genetic pre-
disposition is concerned, it is well established that in
hereditary non-polyposis colon cancer (HNPCC) various
mismatch repair genes are functionally affected. Indivi-
duals with a mutation in one of these genes have an
80% lifetime risk of developing colon cancer [31] and a
well established increased risk of developing extracolo-
nic tumors, including endometrial, ovarian, ureteral, and
renal cancers [32]. Additionally, microsatellite instability
testing in patients with HNPCC has been described as a
cost-effective and feasible method for identifying candi-
dates for HNPCC testing, indicating that microsatellite
instability testing could be applied to patients with col-
orectal and urological cancers.
Conclusion
This report describes for the first time the coexistence
of a colon carcinoma with a combination of two distinct
renal cell carcinomas with different histological sub-
types, papillary and chromophobe, within the left kid-
ney. Such cases underline the need to perform routine
pre-operative imaging studies to exclude synchronous
asymptomatic renal tumors in patients with colorectal
cancer, and after surgery to genetically analyze synchro-
nous tumors in view of detecting common genetic
aberrations.
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